https://unc1999inhibitor.com/s....tats-optimisation-re
TARGETS We aimed to study Mycobacterium tuberculosis (MT-secreted MPT64 as a surrogate of bacterial viability for the diagnosis of active pulmonary tuberculosis (PT and for follow-up therapy. METHODS In our proof-of-concept prospective study, 50 PTB patients in Tokyo metropolitan area between 2017 and 2018 had been included consecutively and 30 healthy people had been included. Each PTB patient submitted sputum on Days 0, 14, and 28 for analysis and follow-up, and each